Quote:
Originally Posted by wehateporn
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.
RESULTS:
The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.
CONCLUSION:
As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. - PubMed - NCBI
|
Remember that any old shit can go on PubMed - Without looking at the paper it's useless, also the data they used was 17 years out of date - A LOT HAS HAPPENED IN THAT TIME - It also doesn't answer my question...
Explain this:
If you have got a genuine interest research Targeted Therapies - It's where the clever money is
.....